Le Lézard
Classified in: Health
Subjects: SVY, WOM, FVT

New Study Reveals 214 Million Women Have an Unmet Need for Modern Contraception


WASHINGTON, Sept. 25, 2017 /PRNewswire/ -- New data released by The Guttmacher Institute shows that of the 885 million women living in developing countries hoping to avoid pregnancy, 214 million of those are not using contraception. DKT International, one of the largest providers of contraceptives and family planning services in the developing world, stresses the importance of World Contraception Day (September 26), held annually to raise awareness and improved access of contraceptives for women worldwide.

"DKT remains committed to increasing access to high quality and affordable contraceptive services. As always, our goal is to give couples the resources they need to choose if and when to become parents," says Christopher Purdy, CEO and President, DKT International. "As a part of its commitment to FP2020, DKT will continue leveraging its social marketing expertise using culturally relevant marketing and educational campaigns to increase the accessibility, availability, and affordability of a wide variety of modern contraceptives."

The new data also estimates that of the 206 million pregnancies in 2017 in developing regions, 43% are unintended- either unplanned or undesired.

"We will continue implementing out-of-the-box tactics and activities to engage, educate, and reach youth populations with messaging of family planning where they need it most," adds Purdy.

 

SOURCE DKT International


These press releases may also interest you

at 16:05
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the full year ended December 31, 2023, and provided an overview of recent developments....

at 16:05
Bristol Myers Squibb today announced an update following the initial analysis of results from the first of two induction studies in the Phase 3 YELLOWSTONE clinical trial program evaluating Zeposia (ozanimod) in adult patients with moderate to...

at 16:05
Personalis, Inc. , a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10 at 1:30 p.m. Eastern Time. About Personalis, Inc....

at 16:05
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December...

at 16:05
Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced fourth quarter and year-end 2023 financial...

at 16:05
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2023...



News published on and distributed by: